HUM · News · 20260806N
Generic Drug Price-Fixing Litigation
HUMANA INC · 2026-08-06 · Importance 34 · Surprise 42 · In source text
Humana’s antitrust claims alleging that generic-drug manufacturers conspired to inflate prices will proceed to a bellwether trial in the U.S. District Court for the Eastern District of Pennsylvania. The trial is intended to test a representative case and may help determine the direction of similar claims. Teva Pharmaceuticals, one of the defendants, is seeking to prevent jurors from being told that it is Israeli, citing potential prejudice related to public sentiment surrounding the Gaza war.
Key facts
- Humana's antitrust claims alleging generic drug price-fixing will proceed to a bellwether trial in the Eastern District of Pennsylvania. source
- Teva Pharmaceuticals asked a U.S. judge to prevent insurer Humana from informing jurors that Teva is an Israeli company in an upcoming drug price-fixing trial, citing concerns about prejudice due to the Gaza war. source
- Teva told a U.S. court that its national origin is irrelevant to allegations of conspiring to inflate generic drug prices and asked to keep Israel ties from the jury. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | contingent | — | Humana's antitrust claims alleging generic drug price-fixing will proceed to a bellwether trial in the Eastern District of Pennsylvania. |